Pharmasset Selected to Join the NASDAQ Biotechnology Index.....           Pipex's pulmonary fibrosis drug granted orphan designation.....           Warner Chilcott and Leo Pharma obtain FDA approval for Taclonex Scalp.....           Intercell to acquire Iomai.....           Thallion to start Phase II brain cancer trial in Canada.....           Medarex starts Phase II trial of anti-inflammation drug.....           Proteome Sciences partners with EU for developing alternatives to animal tests.....           ProStrakan reports encouraging results from Fortigel study.....           ABR-Affinity BioReagents expands distribution partners in Europe.....           FDA approves Novo Nordisk's clot therapy.....           Progenics Q1 loss widens.....           Affymax Q1 net loss rises.....           Repros Q1 revenues fall by 15%.....           Warner Chilcott Q1 revenues rise.....           Javelin to raise $27.6 million in direct offering.....           Canadian Court dismisses patent lawsuit against Boston Scientific.....           Jazz secures $75 million in equity financing.....           Atrium granted approval for hernia repair devices.....           Enterix launches point-of-care cancer screening test.....           CorMatrix granted approval for cardiac implant.....           APP Pharmaceuticals posts rise in Q1 revenues.....           Par Pharmaceutical to Host First Quarter 2008 Earnings Conference Call on May 9 at.....           Barr Announces Approval Of Generic Yasmin.....           Barr sees downturn for 1Q.....           AIG loss, oil, drug firms rattle investors.....           LifeCycle Pharma's dyslipidemia drug found effective in Phase II study.....           Dor BioPharma acquires option for anthrax vaccine from Harvard University.....           BiPar to initiate Phase II ovarian cancer trial.....           Dana-Farber Institute partners with EntreMed in Phase I cancer study.....           Osiris wins approval for Prochymal expanded access program.....           OrthoLogic completes dosing in Phase I dermal scarring trial.....           FDA to boost post marketing safety activities.....           Uluru to launch Altrazeal wound care dressing.....           Collegium presents positive clinical data for oral oxycodone formulation.....           US WorldMeds develops dantrolene sodium injection for hyperthermia.....           Next Pharma's Relora relieves short-term anxiety in healthy women.....           Alpharma presents safety and efficacy data for pain drug.....           Metametrix launches new urinary diagnostic profile.....           Roche's Actemra found effective in arthritis trial.....           Cytopia and Cancer Therapeutics join hands in drug discovery.....           Eusa Pharma acquires Cytogen.....           Ziopharm granted orphan designation for palifosfamide.....           Invitrogen and WARF sign licensing agreement.....           Inverness Medical acquires Matria Healthcare.....           UK court rules against NICE over Alzheimer's guidance.....           Otsuka and Bristol-Myers obtain expanded approval for Abilify.....           Cardima raises $5 million in private placement.....           NuVasive to acquire Osteocel business from Osiris.....           Eli Lilly's Strattera wins FDA approval for maintenance of ADHD.....           Globus Medical completes enrollment for cervical disc clinical trial.....           Degree Scandal Sparks Rare Forum.....           Barr Pharma shares drop after guidance cut, downgrade.....           Cleveland BioLabs completes enrollment for Phase II prostate cancer trial.....           AMDL signs LOI to acquire GLP.....           iCo acquires rights to oral antifungal drug.....           VioQuest granted patent for dermal drug.....           Pipex granted notice of allowance for Alzheimer's drug patent.....           COTI granted European patent for leukemia drugs.....           Acucela files IND application for ocular drug.....           Cynosure wins Korean approval to market Accolade.....           Mylan granted approval to market generic Requip.....           Lipid Sciences granted two new patents.....           Enzon to spin off biotechnology business.....           Astellas's antifungal drug receives European approval.....           Microbix to acquire urokinase from ImaRx.....           ArthroCare's Topaz MicroDebrider found effective against tendon disorders.....           NationsHealth and CIGNA amend preferred vendor agreement.....           Medpace Director of Clinical Pharmacology, Jim Wei, MD, PhD, Embarks........           FDA accepts Osteologix's IND application for osteoporosis drug.....           Fougera granted approval to market generic scalp solution.....           REGiMMUNE raises $8 million in series B financing.....           Pluristem granted approval to conduct arterial disease trials.....           Stanford University to study Pathwork's diagnostic test.....           NovaDel to raise $4 million in financing.....           Vascular Insights wins clearance to market infusion catheter.....           Dilon granted CE Mark for imaging system.....           Clarient partners with JVHL to offer cancer assays.....           Orexigen completes enrollment in Phase III study of obesity drug.....           Catalyst selects new drug candidate for hemophilia program.....           MacroGenics names new CFO and chief commercial officer.....           FDA accepts Osteologix's IND application for osteoporosis drug.....           Poniard completes enrollment of Phase II colorectal cancer trial.....           SDI signs supply agreement with University of North Carolina.....           Clarient partners with JVHL to offer cancer assays.....           Catalyst selects new drug candidate for hemophilia program.....           Dalton Pharma signs licensing agreement with Thermo Fisher Scientific.....           Novartis's meningitis vaccine found effective in Phase III trial.....           NicOx reports encouraging results from Phase IIa glaucoma trial.....           Health Discovery signs LoI with DCL to develop cancer test.....           Peak's tissue dissection tool found effective in preclinical studies.....           Spectrum receives $20 million cash payment from Par Pharmaceutical.....           Teva quarterly net profit down on CoGenesys charge.....           Cardinal Health-brand mouthwash recalled.....           McKesson's 4th-quarter profit rises 19 percent on higher distribution, technology unit sales.....           Minerva announces breakthrough in cancer therapy.....           Xennex licenses GeneCards to Japan Patent Office.....           Senetek reports positive results from rosacea study.....           iClin launches new cancer therapy in Sweden.....           Curis's partner Genentech initiates Phase II colorectal cancer trial.....           NanoViricides's anti-HIV drug candidates found effective in animal studies.....           Roxro wins award for Phase III intranasal pain drug.....           Volcano to participate in AstraZeneca's Saturn trial.....           QRxPharma presents promising Phase III results for pain therapy.....           HeartWare granted conditional approval for cardiac device.....           Targacept to receive milestone payment from GlaxoSmithKline.....           Contura reports efficacy data from Aquamid study.....           Applied DNA Sciences and Smiths Detection sign MoU.....           Indevus reports positive Phase III results for Supprelin LA.....           DiscoveRx and Caliper Life Sciences announce collaboration.....           AstraZeneca files sNDA for Seroquel XR.....           Galapagos and Allergan collaborate in drug discovery.....           UK's R&D in decline, survey finds.....           UK drug firms protest against new pricing deal.....           EU launches major R&D initiative.....           WVU Faculty Senate Calls For President To Quit.....           Advantage Medical obtains FDA approval for VantageCath.....           N30 Pharma completes Phase I asthma trial.....           Minrad to raise $40 million in private placement.....           GE Healthcare signs diagnostic agreement with Merck.....           Mologen to start Phase I study of cancer drug.....           Merck to downsize US sales force.....           McKesson net jumps, beats analyst forecasts.....           St Jude Medical and Microsoft to enhance access to health records.....           MedImmune's motavizumab found effective in Phase III RSV trial.....           Mpathy raises equity and strengthens board of directors.....           Roche exercises option to develop Memory's neurological drug.....           McKesson signs settlement with US Drug Enforcement Administration.....           Bristol-Myers to sell ConvaTec.....           Cell Therapeutics gets favorable opinion to replace brand name.....           Critical Outcome Technologies amalgamates with DDP Therapeutics.....           Canadian regulatory authority accepts Basilea's alitretinoin application.....           Ipsen's Adenuric obtains European marketing authorization.....           Lumenis to implement changes in ophthalmic business unit.....           Epix begins Phase IIb Alzheimer's program.....           Bovie Medical gets CE Mark for laparoscopic line.....           Cardiva Medical completes $15.5 million equity financing.....           WVU President Shares Regret.....           Public Private Partnerships Are Essential To Address Medicines Discovery Slowdown.....            
Future Events
The Academy of Pharmaceutical Sciences organises several major conferences and symposia each year on topics of interest to pharmaceutical scientists. These one-day or two-day symposia are held at the Royal Pharmaceutical Society's headquarters in London.

The Academy of Pharmaceutical Sciences also organises residential training courses on topics to meet the needs of the pharmaceutical and related industries. A feature of these courses, held at centres around the country, is the workshops and tutorials in which delegates apply the new information to practical examples. Led by experts in their fields, these courses provide in-depth training and up to date information.

Further details can be obtained by viewing the science section of the Royal Pharmaceutical Society.
 
Programme of Future Events
4 June 2008 Pharmacogenetics in Context
The Royal Pharmaceutical Society of Great Britain, London
25 - 27 June 2008 Skin Forum 2008
School of Pharmacy, University of London
26 June 2008

 

 "Extreme Characterisation"
Hazelrigg Hall, Loughborough University
Programme sponsored by:
30 June 2008 Ophthalmic Drug Delivery: What is currently available and where are we going?
The Royal Pharmaceutical Society of Great Britain, London
7 - 9 September 2008 BPC 2008, Pharmacy in the 21st Century, Adding years to life and life to years.
Manchester Central
1 - 3 October 2008 “Photostabitity 2008"
The Royal Pharmaceutical Society of Great Britain, London
10 November 2008 Equipping our Students for a Changing Profession
The Royal Pharmaceutical Society of Great Britain, London
24 - 26 November 2008 Tabletting Technology for the Pharmaceutical Industry
The Royal Pharmaceutical Society of Great Britain, London
23 - 25 March 2009 Inhalation 2009 - The changing face of inhalation - fit for the future
University of Nottingham, UK
8 - 12 June 2009 Young Pharmaceutical Scientists PharmSciFair 2009
Nice, France

Registered in England. No 4245751. Registered Office: 840 Melton Road, Thurmaston, Leicester, LE4 8BN